Global Acute Ischemic Stroke Diagnosis Market Major Players 2024, Forecast To 2033
8 Mar, 2024
The acute ischemic stroke diagnosis market has experienced robust growth, increasing from $2.14 billion in 2023 to $2.31 billion in 2024, with a CAGR of 7.6%. This growth is attributed to factors such as the rise in cardiovascular risk factors and telemedicine adoption. Moving forward, the market is expected to see strong growth, reaching $2.99 billion in 2028, with a CAGR of 6.7%. Factors such as remote monitoring technologies and advancements in imaging technologies will drive this growth.
Global Acute Ischemic Stroke Diagnosis Market Key Driver
The rising prevalence of acute ischemic stroke cases is expected to propel the growth of the acute ischemic stroke diagnosis market. In the United States alone, there are more than 795,000 strokes per year, with acute ischemic strokes accounting for around 87% of all strokes, emphasizing the need for early diagnosis to aid in treatment and reduce brain damage.
Get A Free Sample Of The Global Acute Ischemic Stroke Diagnosis Market ReportGlobal Acute Ischemic Stroke Diagnosis Market Segments
The acute ischemic stroke diagnosis market covered in this report is segmented –
1) Diagnostic Type:Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography (ECG), Echocardiography, Other Diagnostics
2) Surgery Type:Carotid Endarterectomy, Angioplasty, Endovascular Mechanical Thrombectomy
3) Application:Tissue Plasminogen Activator (TPA), Anticoagulant, Antiplatelet, Antihypertensive
By Geography: The countries covered in the acute ischemic stroke diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the acute ischemic stroke diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute ischemic stroke diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Acute Ischemic Stroke Diagnosis Industry Players
Cardinal Health Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Sanofi-Aventis LLC; Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Philips Healthcare; Stryker Corporation; GE HealthCare Technologies Inc.; Boston Scientific Corporation; Genentech Inc.; Nihon Kohden Corporation; Neusoft Medical Systems Co. Ltd.; Penumbra Inc.; Insera Therapeutics LLC; MicroVention Inc.; FUJIFILM Medical Systems; Canon Medical Systems Corporation; Silk Road Medical Inc.; Samsung Neurologica Corporation; Mentice AB; NICO Corporation; Imperative Care Inc.; Olea Medical; NovaSignal Corporation; iSchemaView Inc.; Hyperfine Research Inc.; Perfuze Ltd.
Get The Full Global Acute Ischemic Stroke Diagnosis Market Report
Acute Ischemic Stroke Diagnosis Market Overview
An acute ischemic stroke (AIS) diagnosis refers to the diagnosis of a condition characterized by an abrupt loss of blood flow to a portion of the brain, which is accompanied by a loss of neurologic function. Acute ischemic stroke (AIS) diagnosis identifies and detects the sources of the clot that resulted in the abrupt loss of blood flow.